Simon Durand, Yaqi Tang, Roxane M Pommier, Valentin Benboubker, Maxime Grimont, et al.. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions. Oncogene, In press, ⟨10.1038/s41388-024-03010-7⟩. ⟨hal-04526523⟩

Gaël Runel, Noémie Lopez-Ramirez, Laetitia Barbollat-Boutrand, Muriel Cario, Simon Durand, et al.. Cancer Cell Biomechanical Properties Accompany Tspan8-Dependent Cutaneous Melanoma Invasion. Cancers, 2024, 16 (4), pp.694. ⟨10.3390/cancers16040694⟩. ⟨hal-04504695⟩

Stéphane Dalle, Estelle Verronese, Axelle N’kodia, Christine Bardin, Céline Rodriguez, et al.. Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients. OncoImmunology, 2024, 13 (1), pp.2372118. ⟨10.1080/2162402X.2024.2372118⟩. ⟨hal-04632685⟩

Delphine Bredel, Edi Tihic, Séverine Mouraud, François-Xavier Danlos, Sandrine Susini, et al.. Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers. Journal of experimental & clinical cancer research, 2023, 42, ⟨10.1186/s13046-023-02897-6⟩. ⟨hal-04431918⟩

Loraine Jarrosson, Stéphane Dalle, Clélia Costechareyre, Yaqi Tang, Maxime Grimont, et al.. An in vivo avian model of human melanoma to perform rapid and robust preclinical studies. EMBO Molecular Medicine, 2023, 15 (3), ⟨10.15252/emmm.202216629⟩. ⟨hal-04066053⟩

Michele Lodato, Valérie Plaisance, Valérie Pawlowski, Maxime Kwapich, Alexandre Barras, et al.. Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?. Cells, 2023, 12 (6), pp.940. ⟨10.3390/cells12060940⟩. ⟨hal-04062633⟩